BLCO

BLCO

USD

Bausch + Lomb Corporation Common Shares

$12.440+0.040 (0.323%)

リアルタイム価格

Healthcare
Medical Instruments & Supplies
カナダ

価格チャート

Loading Chart...

主要指標

市場指標
企業ファンダメンタルズ
取引統計

市場指標

始値

$12.400

高値

$12.488

安値

$12.240

出来高

0.40M

企業ファンダメンタルズ

時価総額

4.4B

業種

Medical Instruments & Supplies

Canada

取引統計

平均出来高

0.85M

取引所

NYQ

通貨

USD

52週レンジ

安値 $10.45現在値 $12.440高値 $21.69

関連ニュース

PR Newswire

BLCO Investors Have Opportunity to Join Bausch + Lomb Corporation Fraud Investigation with the Schall Law Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Bausch + Lomb ...

もっと見る
BLCO Investors Have Opportunity to Join Bausch + Lomb Corporation Fraud Investigation with the Schall Law Firm
BusinessWire

Bausch + Lomb Announces Launch of Senior Secured Notes Offering and Refinancing of Credit Agreement

Bausch + Lomb Corporation (NYSE/TSX:BLCO) ("Bausch + Lomb" or the "company"), a leading global eye health company dedicated to helping people see better to live better, today announced that its subsidiaries, Bausch+Lomb

もっと見る
Bausch + Lomb Announces Launch of Senior Secured Notes Offering and Refinancing of Credit Agreement
Analyst Upgrades

Barclays Maintains Equal-Weight on Bausch & Lomb, Lowers Price Target to $16

Barclays analyst Matt Miksic maintains Bausch & Lomb with a Equal-Weight and lowers the price target from $19 to $16.

もっと見る
Barclays Maintains Equal-Weight on Bausch & Lomb, Lowers Price Target to $16
PR Newswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch + Lomb Corporation - BLCO

Pomerantz LLP is investigating claims on behalf of investors of Bausch + Lomb Corporation ("Bausch + Lomb" or the "Company") (NYSE: BLCO). Such...

もっと見る
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch + Lomb Corporation - BLCO
GlobeNewswire

Innovations in Imaging, such as AI-Enhanced Retinal & Fundus Camera Systems are Booming Along with Revenue Opportunities

PALM BEACH, Fla., June 04, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The Retinal and Fundis Camera market has shown growth in the recent years and is expected to continue for years to come. Fundus

もっと見る
Innovations in Imaging, such as AI-Enhanced Retinal & Fundus Camera Systems are Booming Along with Revenue Opportunities
PR Newswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch + Lomb Corporation - BLCO

Pomerantz LLP is investigating claims on behalf of investors of Bausch + Lomb Corporation ("Bausch + Lomb" or the "Company") (NYSE: BLCO). Such...

BusinessWire

Bausch + Lomb to Participate in the 2025 Jefferies Global Healthcare Conference

Bausch + Lomb Corporation (NYSE/TSX:BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that Chief Financial Officer Sam Eldessouky is scheduled to